Zura Bio (ZURA) Income Statement (2021 - 2026)
Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for Zura Bio (ZURA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||
Research And Development | 15M (+34.58%) | 11M (-8.28%) | 12M (+37.36%) | 8.70M (-16.91%) | 10M (+13.31%) | 9.24M (+53.23%) | 6.03M (+8.84%) | 5.54M (+54.32%) | 3.59M (-48.12%) | 6.92M (+74.31%) | 3.97M (-85.94%) | 28M (+478.48%) | 4.88M (-68.90%) | 16M (+3635.71%) | 420K (+366.67%) | 90K (-98.80%) | 7.50M | - | - |
Selling General And Administrative | 11M (+44.10%) | 7.46M (-1.45%) | 7.57M (-19.12%) | 9.36M (+6.61%) | 8.78M (+35.29%) | 6.49M (-51.17%) | 13M (+113.67%) | 6.22M (+29.85%) | 4.79M (+22.51%) | 3.91M (-37.14%) | 6.22M (+9.51%) | 5.68M (+100.00%) | 2.84M (+491.67%) | 480K (-26.15%) | 650K (-22.62%) | 840K (+162.50%) | 320K (+1500.00%) | 20K (-33.33%) | 30K |
Operating Expenses | 26M (+38.51%) | 18M (-5.69%) | 20M (+8.08%) | 18M (-6.18%) | 19M (+22.38%) | 16M (-18.58%) | 19M (+64.29%) | 12M (+40.33%) | 8.38M (-22.62%) | 11M (+6.28%) | 10M (-69.95%) | 34M (+339.25%) | 7.72M (-55.50%) | 17M (+1521.50%) | 1.07M (+15.05%) | 930K (-88.11%) | 7.82M (+39000.00%) | 20K (-33.33%) | 30K |
Depreciation And Amortization | 20K (-50.00%) | 40K | - | - | 10K (0.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||
Operating Income | -25.50M (+38.51%) | -18.41M (-5.69%) | -19.52M (+8.08%) | -18.06M (-6.18%) | -19.25M (+22.38%) | -15.73M (-18.58%) | -19.32M (+64.29%) | -11.76M (+40.33%) | -8.38M (-22.62%) | -10.83M (+6.28%) | -10.19M (-69.94%) | -33.90M (+339.12%) | -7.72M (+2759.26%) | -270.00K (-74.77%) | -1.07M (+15.05%) | -930.00K (+126.83%) | -410.00K (+1950.00%) | -20.00K (-33.33%) | -30.00K |
Ebit | -25.50M (+38.51%) | -18.41M (-5.69%) | -19.52M (+8.08%) | -18.06M (-6.18%) | -19.25M (+22.38%) | -15.73M (-18.58%) | -19.32M (+64.29%) | -11.76M (+40.33%) | -8.38M (-22.62%) | -10.83M (+6.28%) | -10.19M (-69.94%) | -33.90M (+339.12%) | -7.72M (+2759.26%) | -270.00K (-74.77%) | -1.07M (+15.05%) | -930.00K (+126.83%) | -410.00K (+1950.00%) | -20.00K (-33.33%) | -30.00K |
EBITDA | -25.48M (+16.24%) | -21.92M (+21.51%) | -18.04M (+12.82%) | -15.99M (-16.89%) | -19.24M (+17.32%) | -16.40M (-20.77%) | -20.70M (+100.39%) | -10.33M (+33.29%) | -7.75M (-8.50%) | -8.47M (+2.42%) | -8.27M (-75.69%) | -34.02M (+254.74%) | -9.59M (-69.53%) | -31.47M (+2760.91%) | -1.10M (+19.57%) | -920.00K | 7.80M | -20.00K (-33.33%) | -30.00K |
Other Income / Expenses | |||||||||||||||||||
Interest Income | 1.32M (+3.13%) | 1.28M (-16.34%) | 1.53M (-11.05%) | 1.72M (-5.49%) | 1.82M (-14.55%) | 2.13M (-13.41%) | 2.46M (+11.82%) | 2.20M (+80.33%) | 1.22M (-10.95%) | 1.37M (+67.07%) | 820K | - | - | - | - | - | - | - | - |
Net Interest Income | 1.32M (+3.13%) | 1.28M (-16.34%) | 1.53M (-11.05%) | 1.72M (-5.49%) | 1.82M (-14.55%) | 2.13M (-13.41%) | 2.46M (+11.82%) | 2.20M (+80.33%) | 1.22M (-10.95%) | 1.37M (+67.07%) | 820K | - | - | - | - | - | - | - | - |
Other Non Operating Income | -40.00K | 6.60M | -50.00K | 350K | - | 2.79M (+13850.00%) | 20K | - | 20K (-99.04%) | 2.08M | - | 10K | -10.00K (-94.12%) | -170.00K (+466.67%) | -30.00K | - | 560K | - | - |
Net Income | |||||||||||||||||||
Income Before Tax | -24.22M (+41.06%) | -17.17M (-4.82%) | -18.04M (+12.82%) | -15.99M (-8.31%) | -17.44M (+28.05%) | -13.62M (-34.20%) | -20.70M (+100.39%) | -10.33M (+33.29%) | -7.75M (-8.50%) | -8.47M (+2.42%) | -8.27M (-75.69%) | -34.02M (+247.50%) | -9.79M (-44.03%) | -17.49M (+1490.00%) | -1.10M (+19.57%) | -920.00K (-88.24%) | -7.82M | - | - |
Net Income From Continuing Operations | -24.22M (+41.06%) | -17.17M (-4.82%) | -18.04M (+12.82%) | -15.99M (-8.31%) | -17.44M (+28.05%) | -13.62M (-34.20%) | -20.70M (+100.39%) | -10.33M (+33.29%) | -7.75M (-8.50%) | -8.47M (+2.42%) | -8.27M (-75.69%) | -34.02M (+254.74%) | -9.59M (-69.53%) | -31.47M (+2760.91%) | -1.10M (+19.57%) | -920.00K | 7.80M | -20.00K (-33.33%) | -30.00K |
Net Income | -24.22M (+41.06%) | -17.17M (-4.82%) | -18.04M (+12.82%) | -15.99M (-8.31%) | -17.44M (+28.05%) | -13.62M (-34.20%) | -20.70M (+100.39%) | -10.33M (+33.29%) | -7.75M (-8.50%) | -8.47M (+2.42%) | -8.27M (-75.69%) | -34.02M (+254.74%) | -9.59M (-69.53%) | -31.47M (+2760.91%) | -1.10M (+19.57%) | -920.00K | 7.80M | -20.00K (-33.33%) | -30.00K |